Takeda Oncology
Jessy Garcia is a seasoned marketing professional with extensive experience in the oncology and biotherapeutics sectors. Currently serving as the Global Colorectal Cancer Senior Brand Manager at Takeda Oncology, Jessy has also operated as a Business Owner at Practice Push Inc., focusing on solutions to enhance patient engagement for practice owners. Previously, Jessy held senior marketing roles at Takeda and Shire, managing significant product portfolios worth billions and leading cross-functional teams in strategic planning and market analysis. Jessy's early career included positions at Cornell University and various internships, showcasing a strong foundation in public relations, engineering, and marketing. Academic credentials include a Bachelor of Science in Mechanical Engineering from Cornell University.
This person is not in any teams
This person is not in any offices
Takeda Oncology
21 followers
In 2008, Takeda Pharmaceutical Company Limited acquired Millennium Pharmaceuticals and the resulting company became exclusively focused on oncology. In 2014, Takeda Oncology was created to become the global headquarters for Takeda’s oncology specialty business unit, in Cambridge, Massachusetts, on the former Millennium Pharmaceuticals site. AtTakeda Oncology they endeavor to deliver novel medicines to patients with cancer worldwide through our commitment to science, breakthrough innovation and passion for improving the lives of patients. This singular focus drives our aspirations to discover, develop and deliver breakthrough oncology therapies. By concentrating the power of leading scientific minds and the vast resources of a global pharmaceutical company, they are finding innovative ways to improve the treatment of cancer.They've built a portfolio of paradigm-changing therapies and a leading oncology pipeline. Though They've made great strides in our fight against cancer, they are determined to do more — to work harder and to reach higher. They continue to seek our aspirations with the same passion, agility and entrepreneurial spirit that has sustained our patient-centric culture and has made us the leaders in oncology that they are today.